Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015 (2015), Article ID 576564, 7 pages
http://dx.doi.org/10.1155/2015/576564
Research Article

Parkinson’s Disease Prevalence and Proximity to Agricultural Cultivated Fields

1Clinical Research Center, Soroka University Medical Center, 84101 Beer Sheva, Israel
2Faculty of Health Sciences, Ben Gurion University, 84101 Beer Sheva, Israel
3Department of Neurology, Soroka University Medical Center, 84101 Beer Sheva, Israel
4Department of Geography and Environmental Development, Faculty of Humanities and Social Sciences, Ben Gurion University, 84101 Beer Sheva, Israel
5Sackler Faculty of Medicine, School of Public Health, Department of Epidemiology, Tel Aviv University, 6997801 Tel Aviv, Israel

Received 23 May 2015; Revised 13 July 2015; Accepted 27 July 2015

Academic Editor: Peter Hagell

Copyright © 2015 Maayan Yitshak Sade et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Dardiotis, G. Xiromerisiou, C. Hadjichristodoulou, A. M. Tsatsakis, M. F. Wilks, and G. M. Hadjigeorgiou, “The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides,” Toxicology, vol. 307, pp. 17–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Chillag-Talmor, N. Giladi, S. Linn et al., “Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large Israeli population,” Journal of Parkinson's Disease, vol. 1, no. 1, pp. 35–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Pedro-Cuesta, E. Rodríguez-Farré, and G. Lopez-Abente, “Spatial distribution of Parkinson's disease mortality in Spain, 1989–1998, as a guide for focused aetiological research or health-care intervention,” BMC Public Health, vol. 9, article 445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Wright Willis, B. A. Evanoff, M. Lian, S. R. Criswell, and B. A. Racette, “Geographic and ethnic variation in Parkinson disease: a population-based study of us medicare beneficiaries,” Neuroepidemiology, vol. 34, no. 3, pp. 143–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Priyadarshi, S. A. Khuder, E. A. Schaub, and S. S. Priyadarshi, “Environmental risk factors and Parkinson's disease: a metaanalysis,” Environmental Research, vol. 86, no. 2, pp. 122–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. O. Herishanu, J. R. Goldsmith, J. M. Abarbanel, and Z. Weinbaum, “Clustering of Parkinson's disease in southern Israel,” Canadian Journal of Neurological Sciences, vol. 16, no. 4, pp. 402–405, 1989. View at Google Scholar · View at Scopus
  7. A. Ascherio, H. Chen, M. G. Weisskopf et al., “Pesticide exposure and risk for Parkinson's disease,” Annals of Neurology, vol. 60, no. 2, pp. 197–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Behari, A. K. Srivastava, R. R. Das, and R. M. Pandey, “Risk factors of Parkinson's disease in Indian patients,” Journal of the Neurological Sciences, vol. 190, no. 1-2, pp. 49–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Frigerio, K. R. Sanft, B. R. Grossardt et al., “Chemical exposures and Parkinson's disease: a population-based case-control study,” Movement Disorders, vol. 21, no. 10, pp. 1688–1692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Kanavouras, M. N. Tzatzarakis, V. Mastorodemos, A. Plaitakis, and A. M. Tsatsakis, “A case report of motor neuron disease in a patient showing significant level of DDTs, HCHs and organophosphate metabolites in hair as well as levels of hexane and toluene in blood,” Toxicology and Applied Pharmacology, vol. 256, no. 3, pp. 399–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Nuti, R. Ceravolo, G. Dell'Agnello et al., “Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy,” Parkinsonism & Related Disorders, vol. 10, no. 8, pp. 481–485, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Costello, M. Cockburn, J. Bronstein, X. Zhang, and B. Ritz, “Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California,” American Journal of Epidemiology, vol. 169, no. 8, pp. 919–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. M. Gatto, S. L. Rhodes, A. D. Manthripragada et al., “Alpha-synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease,” Neuroepidemiology, vol. 35, no. 3, pp. 191–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Ritz and F. Yu, “Parkinson's disease mortality and pesticide exposure in California 1984–1994,” International Journal of Epidemiology, vol. 29, no. 2, pp. 323–329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Wang, S. Costello, M. Cockburn, X. B. Zhang, J. Bronstein, and B. Ritz, “Parkinson's disease risk from ambient exposure to pesticides,” European Journal of Epidemiology, vol. 26, no. 7, pp. 547–555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Li, P. J. Mink, L. J. McIntosh, M. J. Teta, and B. Finley, “Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease,” Journal of Occupational and Environmental Medicine, vol. 47, no. 10, pp. 1059–1087, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Chorfa, C. Lazizzera, D. Bétemps et al., “A variety of pesticides trigger in vitro α-synuclein accumulation, a key event in Parkinson’s disease,” Archives of Toxicology, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. NIIO Israel, “HMO membership,” 2012.
  19. Central Bureau of Statistics, Agricultural Crop Area, by Regional Council, 2014.
  20. Central Bureau of Statistics, Population by Population Group, Religion, Age, Sex and Type of Locality, 2011.
  21. Central Bureau of Statistics, Localities in Israel, Central Bureau of Statistics, 2013, (Hebrew).
  22. Central Bureau of Statistics, Population by District, Sub-District and Religion, Central Bureau of Statistics, 2011.
  23. Central Bureau of Statistics, Land Use in Israel 2004, Central Bureau of Statistics, 2004 (Hebrew).
  24. Central Bureau of Statistics, Land Use in Israel, Central Bureau of Statistics, 2002, (Hebrew).
  25. P. Elliott and D. Wartenberg, “Spatial epidemiology: current approaches and future challenges,” Environmental Health Perspectives, vol. 112, no. 9, pp. 998–1006, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. E. Breslow and D. G. Clayton, “Aproximate inference in generalized linear mixed models,” Journal of the American Statistical Association, vol. 88, no. 421, pp. 9–25, 1993. View at Publisher · View at Google Scholar
  27. M. A. Hely, W. G. J. Reid, M. A. Adena, G. M. Halliday, and J. G. L. Morris, “The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years,” Movement Disorders, vol. 23, no. 6, pp. 837–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. N. R. Szumski and E. M. Cheng, “Optimizing algorithms to identify Parkinson's disease cases within an administrative database,” Movement Disorders, vol. 24, no. 1, pp. 51–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. M. C. van de Vijver, R. A. C. Roos, P. A. F. Jansen, A. J. Porsius, and A. de Boer, “Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records,” Pharmacoepidemiology and Drug Safety, vol. 10, no. 6, pp. 549–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Checkoway and L. M. Nelson, “Epidemiologic approaches to the study of Parkinson's disease etiology,” Epidemiology, vol. 10, no. 3, pp. 327–336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. L. M. de Lau and M. M. Breteler, “Epidemiology of Parkinson's disease,” The Lancet Neurology, vol. 5, no. 6, pp. 525–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Twelves, K. S. M. Perkins, and C. Counsell, “Systematic review of incidence studies of Parkinson's disease,” Movement Disorders, vol. 18, no. 1, pp. 19–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. von Campenhausen, B. Bornschein, R. Wick et al., “Prevalence and incidence of Parkinson's disease in Europe,” European Neuropsychopharmacology, vol. 15, no. 4, pp. 473–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Z.-X. Zhang and G. C. Roman, “Worldwide occurrence of Parkinson's disease: an updated review,” Neuroepidemiology, vol. 12, no. 4, pp. 195–208, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Masalha, E. Kordysh, G. Alpert et al., “The prevalence of Parkinson's disease in an Arab population, Wadi Ara, Israel,” Israel Medical Association Journal, vol. 12, no. 1, pp. 32–35, 2010. View at Google Scholar · View at Scopus
  36. A. Orr-Urtreger, C. Shifrin, U. Rozovski et al., “The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?” Neurology, vol. 69, no. 16, pp. 1595–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Sidransky, M. A. Nalls, J. O. Aasly et al., “Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1651–1661, 2009. View at Publisher · View at Google Scholar · View at Scopus